Tessa Quinn
Fox Chase Cancer Center in Philadelphia, PA, is a nationally ranked hospital with high performance ratings in adult specialties and procedures. It is a National Cancer Institute-designated Comprehensive Cancer Center and is considered the Cancer Hub of the Temple University Health System. The center has a rich history of scientific achievements, including the discovery of the Philadelphia chromosome, the first genetic abnormality associated with human cancer, and has been recognised with awards for nursing excellence. With a wide range of advanced treatments, access to leading physicians, and a full spectrum of care, Fox Chase Cancer Center is a leading cancer hospital.
| Characteristics | Values |
|---|---|
| Location | Philadelphia, Pennsylvania, United States |
| History | The Fox Chase Cancer Center was formed in 1974 when the American Oncologic Hospital (founded in 1904) and the Institute for Cancer Research (founded in 1927) merged. |
| Awards | The Fox Chase Cancer Center has received the American Nurses Association Magnet Award for Nursing Excellence. |
| Ranking | The hospital is nationally ranked in 2 adult specialties and rated high performing in 1 adult specialty and 5 procedures and conditions. |
| Treatments | Robotic-assisted surgeries, targeted immunotherapies, radiation, chemotherapy, pain management, palliative care, and rehabilitation services. |
| Number of Employees | Almost 2,400 employees |
| Operating Budget | $300 million |
| New Patients | More than 14,000 new patients per year |
| Annual Hospital Admissions | 3,500 |
| Outpatient Visits | 125,000 per year |
| Other | The center is home to some of the area's top cancer specialists and offers telehealth options (video and phone consultations). |
Explore related products
What You'll Learn
- Fox Chase Cancer Center is a nationally ranked cancer hospital
- It is a National Cancer Institute-designated Comprehensive Cancer Center
- It offers advanced treatments, including robotic-assisted surgeries and targeted immunotherapies
- It provides access to leading physicians and clinical trials
- The center has a rich history of scientific achievements and discoveries
Fox Chase Cancer Center is a nationally ranked cancer hospital
The center has a rich history of scientific and medical achievements, including the discovery of the Philadelphia chromosome, the first genetic abnormality associated with human cancer, in 1959. It was also the site of the first identification of the hepatitis B virus, a major cause of primary liver cancer, in 1967. Fox Chase has also been recognised with the American Nurses Association Magnet Award for Nursing Excellence.
Fox Chase offers a wide range of advanced treatments, including robotic-assisted surgeries, targeted immunotherapies, radiation, chemotherapy, pain management, palliative care, and rehabilitation services. The center provides access to leading physicians and clinical trials, with a focus on delivering personalised care and improving patient outcomes.
U.S. News ranks Fox Chase Cancer Center nationally in 2 adult specialties, with high performance ratings in 1 adult specialty and 5 procedures and conditions. The hospital is committed to providing exceptional cancer care through advanced technology, the latest treatments, and cutting-edge research.
Behavioral Health Care: Dayton's Haven Hospital Offers Hope
You may want to see also
Explore related products
It is a National Cancer Institute-designated Comprehensive Cancer Center
Fox Chase Cancer Center, part of the Temple University Health System, is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center. It was formed in 1974 when the American Oncologic Hospital (established in 1904) and the Institute for Cancer Research (founded in 1927) united. Fox Chase is one of the first and one of only 51 cancer centers in the nation to receive this designation from the federal government's principal agency for cancer research and training.
The NCI designation is a testament to Fox Chase's commitment to clinical excellence, research expertise, and community health. The center provides both patient care and research, with over 2,000 staff members, including leading physicians and top cancer specialists. Fox Chase offers state-of-the-art treatments, advanced technology, the latest cancer treatments, cutting-edge research, and clinical trials for all types of cancer.
The center has a rich history of scientific discovery and is known for discovering the Philadelphia chromosome and the two-hit hypothesis. Its researchers have won numerous prestigious awards, including two Nobel Prizes, a Kyoto Prize in basic sciences, a Lasker Clinical Research Award, and an Albert Szent-Györgyi Prize for Progress in Cancer Research.
Fox Chase's mission is to prevail over cancer by boldly pursuing scientific discovery, pioneering prevention, and providing compassionate care. It is a founding member of the National Comprehensive Cancer Network, an alliance of leading cancer centers that set the standards for clinical best practices in oncology. The center's affiliation with Temple University has further enhanced its research capabilities, adding members from various university departments and schools of medicine and public health.
In summary, Fox Chase Cancer Center's NCI designation reflects its excellence in cancer care, research, and community health initiatives. With a dedicated staff, advanced treatments, and a history of scientific achievements, Fox Chase continues to make significant contributions to the fight against cancer.
Verdugo Hills Hospital: HMO Insurance Acceptance
You may want to see also
Explore related products
It offers advanced treatments, including robotic-assisted surgeries and targeted immunotherapies
Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center located in Philadelphia, Pennsylvania. It is one of only 51 hospitals in the US to receive this designation. The center was formed in 1974 through the merger of the American Oncologic Hospital, founded in 1904 as one of the first cancer hospitals in the US, and the Institute for Cancer Research, founded in 1927. Fox Chase has a rich history of scientific and medical achievements, including the discovery of the Philadelphia chromosome, the first genetic abnormality associated with human cancer, and the development of the hepatitis B vaccine.
Today, Fox Chase continues to offer advanced treatments and cutting-edge clinical trials. One of the center's key offerings is its wide range of advanced treatments, including robotic-assisted surgeries and targeted immunotherapies. Robotic-assisted surgeries are a type of minimally invasive surgery where the procedure is performed using a robotic system that is controlled by a surgeon. This approach offers several advantages, including improved precision, flexibility, and control during the operation. It also results in smaller incisions, reduced blood loss, faster recovery times, and less scarring for the patient. Robotic-assisted surgeries at Fox Chase are performed by highly skilled surgeons who have undergone specialized training in this field.
Targeted immunotherapies, another cornerstone of Fox Chase's advanced treatment options, involve the use of the patient's immune system to fight cancer. This approach targets specific aspects of a patient's immune function to enhance their natural defences against cancer cells. Immunotherapy can be used alone or in combination with other treatments, such as chemotherapy or radiation therapy. Fox Chase's immunotherapy treatments are tailored to each patient's unique needs, taking into account the type and stage of cancer, as well as individual health characteristics.
The center's commitment to innovation is further demonstrated by its participation in groundbreaking clinical trials. Fox Chase provides patients with access to leading physicians and cutting-edge clinical trials, such as the INSITE clinical trial, which aims to help bladder cancer patients avoid unnecessary surgical removal of their bladders. By collaborating with other respected healthcare providers, such as Temple University Hospital, Fox Chase ensures that patients benefit from the combined expertise and resources of multiple institutions.
In addition to its advanced treatments, Fox Chase also offers a holistic approach to patient care. The center provides access to various support services, including oncology nurse navigators, dietitians specializing in cancer care, and social work staff who provide counselling and assist with accessing assistance programs. Fox Chase's dedication to patient-centred care has been recognized through awards such as the American Nurses Association Magnet Award for Nursing Excellence, which the center has received multiple times.
Open MRI Availability at OSU Hospital
You may want to see also
Explore related products
It provides access to leading physicians and clinical trials
Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center and research facility with a rich history of scientific achievements and advancements in cancer treatment and research. The center is affiliated with Temple University Health System and is considered the "Cancer Hub" of the university's health system.
The center provides access to leading physicians and specialists dedicated to diagnosing, treating, and managing all types of cancer. With a staff of over 2,000, including hundreds of physicians and scientists, patients at Fox Chase benefit from unparalleled access to a vast network of specialists. The center also has a wide range of advanced treatment options, including robotic-assisted surgeries, targeted immunotherapies, radiation, chemotherapy, pain management, palliative care, and rehabilitation services.
In addition to its medical staff, Fox Chase offers access to groundbreaking clinical trials and treatments. The center is committed to discovering new treatments and delivering better outcomes through its participation in clinical trials. For instance, Dr. Alexander Kutikov and Dr. Matthew Zibelman are currently collaborating on the INSITE clinical trial, which aims to help bladder cancer patients avoid unnecessary surgical removal of their bladders. Fox Chase is also a founding member of the National Comprehensive Cancer Network, an alliance of leading cancer centers that set the accepted standards of clinical best practice in oncology.
The center's affiliation with Temple University has further enhanced its research capabilities, with the addition of research members from multiple university departments, the Lewis Katz School of Medicine, and the College of Public Health. This collaboration allows Fox Chase to offer patients access to cutting-edge research and the latest advancements in cancer treatment.
Fox Chase also provides telehealth options, including video and phone consultations, allowing patients to remotely connect with their care team and receive world-class care from the comfort of their homes.
Hospitals' Medical Records: Sharing and Privacy
You may want to see also
Explore related products
The center has a rich history of scientific achievements and discoveries
Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center and research facility with a rich history of scientific achievements and discoveries. The center was formed in 1974 through the merger of the American Oncologic Hospital, founded in 1904 as one of the first cancer hospitals in the United States, and the Institute for Cancer Research, founded in 1927.
The center has a long-standing commitment to cancer research and innovation. In 1962, under the leadership of Timothy Talbot, the Institute for Cancer Research was one of the first four institutions to obtain a Cancer Center Support Grant (CCSG) from the National Cancer Institute. This grant provided crucial support for scientific advancements and infrastructure development. Fox Chase has successfully retained this grant for over half a century, demonstrating its consistent excellence in cancer research.
The center has been at the forefront of several significant discoveries in the field of oncology. In 1960, David Hungerford of Fox Chase Cancer Center, along with Peter Nowell of the University of Pennsylvania, discovered the Philadelphia chromosome, which was the first genetic abnormality associated with human cancer. This discovery paved the way for a deeper understanding of the genetic underpinnings of cancer. Additionally, the center has been home to renowned scientists such as Beatrice Mintz, a pioneering cancer researcher who made significant contributions to embryonic and genetic research. In 1993, Mintz produced the first mouse model of human malignant melanoma, providing valuable insights into the disease.
Fox Chase Cancer Center has also been a hub for translational medicine, aiming to translate scientific discoveries into practical applications that benefit patients. The center's research initiatives focus on discovering diagnostic and prognostic biomarkers, devices, and therapeutics to positively impact individuals at risk of cancer and those currently battling the disease. This translational approach is evident in the development of targeted immunotherapies, palliative care, and rehabilitation services offered at the center.
The center's commitment to scientific excellence is further highlighted by its involvement in groundbreaking clinical trials. Collaborating on the INSITE clinical trial, Dr. Alexander Kutikov and Dr. Matthew Zibelman are dedicated to helping bladder cancer patients avoid unnecessary surgical procedures. This involvement in cutting-edge research ensures that patients at Fox Chase Cancer Center have access to the latest advancements in cancer treatment.
Hospitality Sector: A Massive Job Creator
You may want to see also
Frequently asked questions
Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in Philadelphia, Pennsylvania. It is ranked nationally by US News and rated high-performing in 1 adult specialty and 5 procedures and conditions. Fox Chase has a rich history of scientific achievements and is considered the "Cancer Hub" of the Temple University Health System.
Fox Chase Cancer Center has a long history of scientific achievements and contributions to cancer research. Some notable achievements include:
- The discovery of the Philadelphia chromosome, the first genetic abnormality associated with human cancer, in 1959.
- The development of the first hepatitis B vaccine by Irving Millman and Baruch Blumberg.
- The cloning of the AKT1 and AKT2 genes, the first viral oncogenes that inhibit programmed cell death.
- The award-winning nursing excellence, being the first US cancer center to receive the American Nurses Association Magnet Award.
Fox Chase Cancer Center offers a wide range of advanced treatments, including robotic-assisted surgeries, targeted immunotherapies, radiation, chemotherapy, pain management, palliative care, and rehabilitation services. They also provide access to leading physicians, cutting-edge clinical trials, and telehealth options for remote consultations.
